 risk agranulocytosi aplast anemia relat use cardiovascular drug intern agranulocytosi aplast anemia studi risk agranulocytosi aplast anemia relat use cardiovascular drug population-bas case-control studi israel europ total popul cardiovascular drug use week onset ill patient agranulocytosi control subject propranolol rel risk dipyridamol digoxin acetyldigoxin agranulocytosi excess risk attribut drug case person week risk cinepazid case control aprindin crude rel risk estim excess risk latter drug person week use cardiovascular drug period month hospit admiss patient aplast anemia control subject furosemid drug rel risk excess risk attribut exposur interv